SKILLMAN, N.J. — Matrixx Initiatives on Tuesday announced its second overture to ProPhase Labs with an increased acquisition offer of $1.60 per share. The revised offer represents a premium of ...

ProPhase Labs’ Linebacker-1 Cancer Therapeutic shows promising mechanisms of action as both a mono-therapy and co-therapy in preclinical studies attacking a range of hard-to-treat cancers ...

ProPhase Labs (PRPH) announced the closing of a private placement financing with two investors for $3 million in senior secured convertible notes ...

ProPhase Labs, Inc. PRPH shares rallied 9.1% in the last trading session to close at $14.15. This move can be attributable to notable volume with a higher number of shares being traded than in a ...

Company to hold a conference call Thursday, May 11, 2023, at 11:00 AM ET. Garden City, NY, May 11, 2023 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a next generation biotech, genomics ...

ProPhase Labs press release (NASDAQ:PRPH): FY GAAP EPS of $1.02 misses by $0.10. Revenue of $122.65M (+55.2% Y/Y) beats by $1.31M. cash and cash equivalents and restricted cash as of December 31 ...

--ProPhase Labs, Inc., a next-generation biotech, genomics and diagnostics company, is pleased to announce that Ted Karkus, CEO, has been named one of Inc Magazine’ s 10 Most Innovative ...

ProPhase Labs earnings missed by $1.62, revenue topped estimates. Open in App ...

Garden City, NY, May 03, 2023 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (PRPH) (“ProPhase”), a next-generation biotech, genomics and diagnostics company, today provided an update regarding its ...

ProPhase Labs Announces Financial Results for the Three Months Ended March 31, 2025 Provided by GlobeNewswire May 20, 2025, 12:00:00 PM.

NEW YORK (MarketWatch) -- Matrixx Initiatives Inc. on Tuesday increased its buyout offer for ProPhase Labs Inc. by 14% to $1.60 a share in cash from its earlier offer of $1.40 a share. Shares of ...